These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 24220143)

  • 21. Menstrual disorders in adolescence: a marker for hyperandrogenaemia and increased metabolic risks in later life? Finnish general population-based birth cohort study.
    Pinola P; Lashen H; Bloigu A; Puukka K; Ulmanen M; Ruokonen A; Martikainen H; Pouta A; Franks S; Hartikainen AL; Järvelin MR; Morin-Papunen L
    Hum Reprod; 2012 Nov; 27(11):3279-86. PubMed ID: 22933528
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum hormone levels and anthropometric characteristics in girls with hyperandrogenism.
    Zukauskaite S; Seibokaite A; Lasas L; Lasiene D; Urbonaite B; Kiesylyte J
    Medicina (Kaunas); 2005; 41(4):305-12. PubMed ID: 15864003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is acne a sign of androgen excess disorder or not?
    Uysal G; Sahin Y; Unluhizarci K; Ferahbas A; Uludag SZ; Aygen E; Kelestimur F
    Eur J Obstet Gynecol Reprod Biol; 2017 Apr; 211():21-25. PubMed ID: 28178574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperandrogenemia in polycystic ovary syndrome: exploration of the role of free testosterone and androstenedione in metabolic phenotype.
    Lerchbaum E; Schwetz V; Rabe T; Giuliani A; Obermayer-Pietsch B
    PLoS One; 2014; 9(10):e108263. PubMed ID: 25310562
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J; Bergh T; Gennarelli G; Wide L
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study of plasma ghrelin levels in women with polycystic ovary syndrome, in hyperandrogenic women and in normal controls.
    Panidis D; Farmakiotis D; Koliakos G; Rousso D; Kourtis A; Katsikis I; Asteriadis C; Karayannis V; Diamanti-Kandarakis E
    Hum Reprod; 2005 Aug; 20(8):2127-32. PubMed ID: 15890737
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.
    Knochenhauer ES; Key TJ; Kahsar-Miller M; Waggoner W; Boots LR; Azziz R
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3078-82. PubMed ID: 9745406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationships between dehydroepiandrosterone-sulphate and anthropometric, metabolic and hormonal variables in a large cohort of obese women.
    Maccario M; Mazza E; Ramunni J; Oleandri SE; Savio P; Grottoli S; Rossetto R; Procopio M; Gauna C; Ghigo E
    Clin Endocrinol (Oxf); 1999 May; 50(5):595-600. PubMed ID: 10468925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgen profile in Chinese women with polycystic ovary syndrome in their reproductive years.
    Zhou Z; Li R; Qiao J
    Reprod Biomed Online; 2017 Sep; 35(3):331-339. PubMed ID: 28684272
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of adrenal androgen excess in patients with the polycystic ovary syndrome (PCOS).
    Kumar A; Woods KS; Bartolucci AA; Azziz R
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):644-9. PubMed ID: 15943823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adrenal androgen excess in hyperandrogenism: relation to age and body mass.
    Morán C; Knochenhauer E; Boots LR; Azziz R
    Fertil Steril; 1999 Apr; 71(4):671-4. PubMed ID: 10202877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the efficacy of different androgens measured by LC-MS/MS in representing hyperandrogenemia and an evaluation of adrenal-origin androgens with a dexamethasone suppression test in patients with PCOS.
    Chen F; Chen M; Zhang W; Yin H; Chen G; Huang Q; Yang X; Chen L; Lin C; Yin G
    J Ovarian Res; 2021 Feb; 14(1):32. PubMed ID: 33583431
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyperandrogenicity is an alternative mechanism underlying oligomenorrhea or amenorrhea in female athletes and may improve physical performance.
    Rickenlund A; Carlström K; Ekblom B; Brismar TB; von Schoultz B; Hirschberg AL
    Fertil Steril; 2003 Apr; 79(4):947-55. PubMed ID: 12749436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics and contributions of hyperandrogenism to insulin resistance and other metabolic profiles in polycystic ovary syndrome.
    Huang R; Zheng J; Li S; Tao T; Ma J; Liu W
    Acta Obstet Gynecol Scand; 2015 May; 94(5):494-500. PubMed ID: 25711494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum androgen levels and muscle mass in women with polycystic ovary syndrome.
    Douchi T; Yamamoto S; Oki T; Maruta K; Kuwahata R; Nagata Y
    Obstet Gynecol; 1999 Sep; 94(3):337-40. PubMed ID: 10472855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Defining Hyperandrogenism in Women With Polycystic Ovary Syndrome: A Challenging Perspective.
    Pasquali R; Zanotti L; Fanelli F; Mezzullo M; Fazzini A; Morselli Labate AM; Repaci A; Ribichini D; Gambineri A
    J Clin Endocrinol Metab; 2016 May; 101(5):2013-22. PubMed ID: 26964728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Causes, Patterns, and Severity of Androgen Excess in 1205 Consecutively Recruited Women.
    Elhassan YS; Idkowiak J; Smith K; Asia M; Gleeson H; Webster R; Arlt W; O'Reilly MW
    J Clin Endocrinol Metab; 2018 Mar; 103(3):1214-1223. PubMed ID: 29342266
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of combined cyproterone acetate-ethinyl oestradiol therapy on serum levels of dehydroepiandrosterone, androstenedione, and testosterone in hirsute women.
    Frölich M; Lachinsky N; Moolenaar AJ
    Acta Endocrinol (Copenh); 1977 Feb; 84(2):333-42. PubMed ID: 138326
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3 beta-hydroxysteroid dehydrogenase deficiency in hyperandrogenism.
    Azziz R; Bradley EL; Potter HD; Boots LR
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):889-95. PubMed ID: 8456898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating androgen levels and self-reported sexual function in women.
    Davis SR; Davison SL; Donath S; Bell RJ
    JAMA; 2005 Jul; 294(1):91-6. PubMed ID: 15998895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.